Baseline characteristics were similar between the P and N + I groups, notably in terms of age, ECOG-PS, tumor location, and tumor computed tomography (CT) staging, except for a nonsignificant trend toward more clinically T4 tumors in the N + I group.
← all excerpts
Neoadjuvant immunotherapy for nonmetastatic dMMR/MSI colon cancer: a real-world retrospective AGEO study.
1
—
—